<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04046796</url>
  </required_header>
  <id_info>
    <org_study_id>DISCO-TWIN</org_study_id>
    <nct_id>NCT04046796</nct_id>
  </id_info>
  <brief_title>Genetic Causes of Discrepant Clinic in Monogenic Twins</brief_title>
  <acronym>DISCO-TWIN</acronym>
  <official_title>Genetic Causes of Discrepant Clinic in Monogenic Twins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the DISCO-TWIN study (prospective, open-label molecular-genetic study), twin pairs with
      one healthy and one affected twin with molecularly undiagnosed diseases will be analysed by
      means of omics technologies and/ or re-analysed using existing datasets. Phenotype and omics
      data will be shared within the University Hospital Tübingen and with external collaborators
      to improve the diagnostic rate of the subjects included in the study.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2019</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of new Candidate Genes</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of new Candidate Genes for complex or serious diseases through a comparative genetic analysis of monozygotic clinically discordant twins</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of putative disease causes</measure>
    <time_frame>Day 1</time_frame>
    <description>Number characterizations of the identified putative disease causes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of diagnosis</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of patients receiving appropriate therapy after successful diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of molecular causes of diagnostically unclear rare diseases</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of molecular causes of diagnostically unclear rare diseases</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Rare Diseases</condition>
  <condition>Genetic Predisposition to Disease</condition>
  <arm_group>
    <arm_group_label>Healthy twin</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Effected Twin</arm_group_label>
    <description>Twin with unclear rare diseases, clinically characterized in the context of outpatient/ inpatient standard care at the University Hospital Tübingen (UKT) or cooperating location.</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>NGS Diagnostic</intervention_name>
    <description>Blood take for genetic diagnostic.</description>
    <arm_group_label>Effected Twin</arm_group_label>
    <arm_group_label>Healthy twin</arm_group_label>
    <other_name>Omics Technology</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sampling for NGS analysis and other omics analysis (transcriptomics, proteomics,
      metabolomics), functional cell biology studies (for example in fibroblast cultures).
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Twin pair monozygotic clinically (phenotypic) discordant twins
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Twin pair monozygotic clinically (phenotypic) discordant twins

          -  Unclear diagnosis

          -  Suspected (mono-)genetic cause of the disease in one twin

        Exclusion Criteria:

          -  Missing informed consent of both twin/ legal representative

          -  No distinct phenotype
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Jeannette Hübener-Schmid</last_name>
    <phone>+49 7071 29</phone>
    <phone_ext>72276</phone_ext>
    <email>jeannette.huebener@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andreas Dufke, PD Dr.</last_name>
    <phone>+49 7071 29</phone>
    <phone_ext>86413</phone_ext>
    <email>andreas.dufke@med.uni-tuebingen.de</email>
  </overall_contact_backup>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 2, 2019</study_first_submitted>
  <study_first_submitted_qc>August 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2019</study_first_posted>
  <last_update_submitted>August 2, 2019</last_update_submitted>
  <last_update_submitted_qc>August 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rare Diseases</keyword>
  <keyword>Genetic Predisposition</keyword>
  <keyword>Omics Technology</keyword>
  <keyword>Next Generation Sequencing (NGS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rare Diseases</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

